Strategic Analysis of the U.S. Biopharmaceuticals Market
Strategic Analysis of the U.S. Biopharmaceuticals Market
RELEASE DATE
02-Dec-2008
02-Dec-2008
REGION
North America
North America
Research Code: N505-01-00-00-00
SKU: HC02105-NA-MR_07568
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02105-NA-MR_07568
Description
This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.
Table of Contents
Executive Summary
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Introduction
- Market Engineering Measurements
- Introduction
- Main Classes of Biopharmaceuticals
- Recent Product Approvals
- Competitive Structure
Market Trends
- Hot Topics and Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Pipeline Analysis
- Introduction
- Antisense Therapies
- Gene and Cell Therapies
- Hormones and Proteins
- Interferons and Interleukins
- Monoclonal Antibodies
- Vaccines
- Others
Total Market Forecasts
Select Sub Market Forecasts
Oncology Databases
Autoimmune and Inflammatory Disorders Databases
Organ Transplants Databases
Cardiovascular Disorders
Neurodegenerative Disorders Databases
- Cancer Cases
- Incidence of Breast Cancer
- Incidence of Colon and Rectum Cancer
- Incidence of Bladder Cancer
- Incidence of Lung Cancer
- Incidence of Stomach Cancer
Respiratory Disorders Databases
- Prevalence of Arthritis
- Prevalence of Psoriasis
- Prevalence of Multiple Sclerosis
Miscellaneous Databases
- The Total Number of Kidney Transplants
- Total Number of Heart Transplants
- Total Number of Liver Transplants
Popular Topics
This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N505-01-00-00-00 |
Is Prebook | No |